dipyridamole has been researched along with Cancer of Prostate in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole (DIP) is a vasodilator and antithrombotic drug." | 1.51 | Dipyridamole impairs autophagic flux and exerts antiproliferative activity on prostate cancer cells. ( Guma, FT; Ilha, M; Lenz, G; Onzi, GR; Pereira, LC; Rohden, F; Thomé, MP; Wink, MR, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Longo, J | 1 |
| Mullen, PJ | 1 |
| Yu, R | 1 |
| van Leeuwen, JE | 1 |
| Masoomian, M | 1 |
| Woon, DTS | 1 |
| Wang, Y | 1 |
| Chen, EX | 1 |
| Hamilton, RJ | 1 |
| Sweet, JM | 1 |
| van der Kwast, TH | 1 |
| Fleshner, NE | 1 |
| Penn, LZ | 1 |
| Thomé, MP | 1 |
| Pereira, LC | 1 |
| Onzi, GR | 1 |
| Rohden, F | 1 |
| Ilha, M | 1 |
| Guma, FT | 1 |
| Wink, MR | 1 |
| Lenz, G | 1 |
| Passer, BJ | 1 |
| Cheema, T | 1 |
| Zhou, B | 1 |
| Wakimoto, H | 1 |
| Zaupa, C | 1 |
| Razmjoo, M | 1 |
| Sarte, J | 1 |
| Wu, S | 1 |
| Wu, CL | 1 |
| Noah, JW | 1 |
| Li, Q | 1 |
| Buolamwini, JK | 1 |
| Yen, Y | 1 |
| Rabkin, SD | 1 |
| Martuza, RL | 1 |
| Goda, AE | 1 |
| Yoshida, T | 1 |
| Horinaka, M | 1 |
| Yasuda, T | 1 |
| Shiraishi, T | 1 |
| Wakada, M | 1 |
| Sakai, T | 1 |
| Koiso, K | 1 |
| Akima, H | 1 |
| Niijima, T | 1 |
| Singh, D | 1 |
| Doroshow, JH | 1 |
| Leong, L | 1 |
| Margolin, K | 1 |
| Akman, S | 1 |
| Raschko, J | 1 |
| Somlo, G | 1 |
| Morgan, R | 1 |
| Harrison, J | 1 |
| Cho, J | 1 |
1 trial available for dipyridamole and Cancer of Prostate
| Article | Year |
|---|---|
Phase II trial of 5-fluorouracil, high-dose leucovorin calcium, and dipyridamole in advanced prostate cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dipyridamole; Fluorouracil; Humans; Leucovorin | 1992 |
5 other studies available for dipyridamole and Cancer of Prostate
| Article | Year |
|---|---|
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dipyridamole; Drug Repos | 2019 |
Dipyridamole impairs autophagic flux and exerts antiproliferative activity on prostate cancer cells.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Agents; Autophagosomes; Autophagy; Cell Divis | 2019 |
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
Topics: Animals; Combinatorial Chemistry Techniques; Dilazep; Dipyridamole; Equilibrative Nucleoside Transpo | 2010 |
Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Topics: Apoptosis; Blotting, Northern; Bone Neoplasms; Colonic Neoplasms; Cyclic AMP-Dependent Protein Kinas | 2008 |
Prevention of platelet aggregation in patients with prostatic cancer during estrogen therapy.
Topics: Aged; Blood Coagulation Tests; Blood Platelets; Cyclic AMP; Dipyridamole; Fibrinolysis; Hexestrol; H | 1982 |